Search

Your search keyword '"Seungjoon Oh"' showing total 155 results

Search Constraints

Start Over You searched for: Author "Seungjoon Oh" Remove constraint Author: "Seungjoon Oh"
155 results on '"Seungjoon Oh"'

Search Results

1. Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology

2. Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement

3. Analysis of diabetes quality assessment findings and future directions for the appropriate management of diabetes in Korea

4. Cardio-Ankle Vascular Index as a Surrogate Marker of Early Atherosclerotic Cardiovascular Disease in Koreans with Type 2 Diabetes Mellitus

5. Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus

6. Acromegaly due to a Macroinvasive Plurihormonal Pituitary Adenoma and a Rectal Carcinoid Tumor

7. The Role of Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes: Understanding How Data Can Inform Clinical Practice in Korea

8. A Smartphone Application Significantly Improved Diabetes Self-Care Activities with High User Satisfaction

9. Celiac Disease in a Predisposed Subject (HLA-DQ2.5) with Coexisting Graves' Disease

10. Insufficient Experience in Thyroid Fine-Needle Aspiration Leads to Misdiagnosis of Thyroid Cancer

11. Risk Factors for the Progression of Intima-Media Thickness of Carotid Arteries: A 2-Year Follow-Up Study in Patients with Newly Diagnosed Type 2 Diabetes

12. Hemoglobin A1c May Be an Inadequate Diagnostic Tool for Diabetes Mellitus in Anemic Subjects

13. Serum Adiponectin and Type 2 Diabetes: A 6-Year Follow-Up Cohort Study

14. Autoimmune Hypoglycemia in a Patient with Characterization of Insulin Receptor Autoantibodies

15. Sarcopenia is independently associated with cardiovascular disease in older Korean adults: the Korea National Health and Nutrition Examination Survey (KNHANES) from 2009.

16. Investigation of Responsiveness to Thyrotropin-Releasing Hormone in Growth Hormone-Producing Pituitary Adenomas

17. Efficacy and safety of monotherapy with enavogliflozin in Korean patients with type 2 diabetes mellitus: Results of a 12‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase 2 trial

18. Author response for 'Efficacy and Safety of Monotherapy with Enavogliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results of a 12‐week, multi‐center, randomized, double‐blind, placebo‐controlled, phase 2 trial'

19. Efficacy and safety of enavogliflozin, a novel <scp>SGLT2</scp> inhibitor, in Korean people with type 2 diabetes: A 24‐week, multicentre, randomized, double‐blind, placebo‐controlled, phase <scp>III</scp> trial

20. Does Board Demographic Diversity Enhance Cognitive Diversity and Monitoring?

21. Author response for 'Efficacy and safety of enavogliflozin, a novel <scp>SGLT2</scp> inhibitor, in Korean people with type 2 diabetes: a 24‐week, multicentre, randomised, double‐blind, placebo‐controlled, phase <scp>III</scp> trial'

22. Cross-listing, foreign independent directors and firm value

23. Cross-listing and the Value of Corporate Cash Holdings : Evidence from China

24. Diagnosis and Treatment of Growth Hormone Deficiency: A Position Statement from Korean Endocrine Society and Korean Society of Pediatric Endocrinology

26. Analysis of diabetes quality assessment findings and future directions for the appropriate management of diabetes in Korea

27. Natural Disasters and the Role of Regional Lenders in Economic Recovery

32. 1544-P: Associations between Dietary Factors and Serum Aryl Hydrocarbon Receptor Bioactivity as a Biomarker of Persistent Organic Pollutants in Prediabetic Population

33. The Effect of Institutional Investor Portfolio Diversification on Corporate Diversification

34. Cardio-Ankle Vascular Index as a Surrogate Marker of Early Atherosclerotic Cardiovascular Disease in Koreans with Type 2 Diabetes Mellitus

35. Fire-sale acquisitions and intra-industry contagion

36. Perfluorooctanoic acid induces oxidative damage and mitochondrial dysfunction in pancreatic β-cells

37. Board Diversity, Director Dissent, and Monitoring Effectiveness

38. Information Transparency in Drug Development: Evidence from Mandatory Disclosure of Clinical Trials

39. Tetrabromobisphenol A Promotes the Osteoclastogenesis of RAW264.7 Cells Induced by Receptor Activator of NF-kappa B Ligand In Vitro

40. The collateral channel: Dynamic effects of housing market on entrepreneurship

41. Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus

43. Inter-Firm Patent Litigation and Innovation Competition

44. Celiac Disease in a Predisposed Subject (HLA-DQ2.5) with Coexisting Graves' Disease

46. Tetrabromobisphenol A induces cellular damages in pancreatic β-cells in vitro

47. Exposure to tetrabromobisphenol A induces cellular dysfunction in osteoblastic MC3T3-E1 cells

48. Insufficient Experience in Thyroid Fine-Needle Aspiration Leads to Misdiagnosis of Thyroid Cancer

49. Perfluorooctanoic acid induces mitochondrial dysfunction in MC3T3-E1 osteoblast cells

50. The choice between PIPE and SEO in China

Catalog

Books, media, physical & digital resources